Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What are the implications of a VP shunt located in the radiation field in a patient receiving treatment for breast cancer?
Should the VP shunt be moved prior to RT? Are there any complications of radiating a VP shunt?
Answer from: Radiation Oncologist at Community Practice
I don’t see any contradiction to RT here.
Sign In
or
Register
to read more
7934
Related Questions
Is ultrahypofractionation appropriate for a B51 candidate receiving breast-only radiation?
Is there additional concern for late cardiac toxicity when using ultrahypofractionated breast radiation protocols, given that the BED to the heart is higher?
How would you approach reirradiation in a patient with a history of whole-breast RT many years ago, now with a small intermediate-grade DCIS s/p lumpectomy with an elevated DCISionRT?
How would you treat a schwannoma of the breast with a positive margin that is not amenable to re-excision?
Do you boost a breast cavity for a high Ki-67 index in the absence of other risk factors?
What are your top takeaways in Radiation Oncology from SABCS 2025?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
In what circumstances would you offer axillary re-irradiation after salvage axillary dissection?
How would you manage an isolated nodal recurrence of breast cancer in a patient with a prior history of mantle-field radiation?
Is it appropriate to consider ultra-hypofractionation for phyllodes tumors of the breast when adjuvant radiotherapy is indicated?